Xeljanz is a medication used in the management of rheumatoid arthritis, a chronic autoimmune condition that causes joint pain, swelling, and stiffness. Modern rheumatoid arthritis care focuses on reducing inflammation, preventing joint damage, and improving quality of life. Xeljanz works by targeting specific pathways involved in the immune response.
Rheumatoid arthritis is a long-term autoimmune disease that primarily affects the joints. Advances in medical research have introduced several treatment options that help manage symptoms and slow disease progression. Among these therapies, Xeljanz has become an important option for some patients. Modern rheumatoid arthritis care combines medication, lifestyle adjustments, and regular medical supervision to support better health outcomes.